Brand / Medicines

Our Medicines

Access the Mundipharma Opioid Analgesic Identification Chart

Image
Chart
Access here

BUPREDERMAL® PATCH

transdermal buprenorphine matrix patch

Product Information Consumer Medicine Information

NORSPAN® PATCH

transdermal buprenorphine matrix patch

Product Information Consumer Medicine Information

OXYCONTIN® TABLETS

modified release oxycodone hydrochloride

Product Information Consumer Medicine Information

OXYNORM® INJECTION

immediate release oxycodone hydrochloride

Product Information for injection Consumer Medicine Information

TARGIN® TABLETS

modified release oxycodone and modified release naloxone hydrochloride dihydrate

Product Information Consumer Medicine Information

MS CONTIN® TABLETS

modified release morphine sulfate

Product Information Consumer Medicine Information

DILAUDID® TABLETS

immediate release hydromorphone hydrochloride

Product Information Consumer Medicine Information

DILAUDID® & DILAUDID®HP INJECTIONS

hydromorphone hydrochloride

Product Information for injection Consumer Medicine Information

Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is required at initiation, maintenance and tapering of opioid therapy.

 

Mundipharma is not promoting the use of strong opioids in chronic non-cancer pain.

 

® NORSPAN, BUPREDERMAL, OXYCONTIN, OXYNORM, MS CONTIN, DILAUDID and TARGIN are registered trade marks of Mundipharma.

Reporting adverse events

Adverse events should be reported. Reporting forms and information can be found at https://aems.tga.gov.au/

Adverse events can also be reported to Mundipharma at drugsafety@mundipharma.com.au